These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6353067)

  • 21. Synergy of Bacteroides fragilis and Escherichia coli in the induction of KC gene expression in mouse peritoneal tissues.
    Kim JM; Kim YJ; Cho YJ
    Scand J Infect Dis; 2000; 32(6):643-9. PubMed ID: 11200375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonic effect of the inhibition of inducible nitric oxide on the mortality of mice acutely infected with Escherichia coli and Bacteroides fragilis.
    Astolfi RS; Khouri DG; Brandizzi LI; Avila-Campos MJ; Andrade HF
    Braz J Med Biol Res; 2007 Mar; 40(3):317-22. PubMed ID: 17334528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the transport of Bacteroides fragilis and Escherichia coli within saturated sand packs.
    Johanson JJ; Feriancikova L; Banerjee A; Saffarini DA; Wang L; Li J; Grundl TJ; Xu S
    Colloids Surf B Biointerfaces; 2014 Nov; 123():439-45. PubMed ID: 25448721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
    Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
    J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro stimulation of Bacteroides fragilis growth by Escherichia coli.
    Hagen JC; Wood WS; Hashimoto T
    Eur J Clin Microbiol; 1982 Dec; 1(6):338-43. PubMed ID: 6761111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
    Soriano F; Ponte MC; Gaspar MC
    J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The variable response of bacteria to free haemoglobin in the tissues.
    Maskell JP; Miles AA
    J Med Microbiol; 1984 Dec; 18(3):377-84. PubMed ID: 6438325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early events after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; MacLaren DM
    J Med Microbiol; 1991 Jul; 35(1):18-22. PubMed ID: 2072375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds.
    Kelly MJ
    J Med Microbiol; 1978 Nov; 11(4):513-23. PubMed ID: 364068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed cultures.
    Schaumann R; Goldstein EJ; Forberg J; Rodloff AC
    J Med Microbiol; 2005 Aug; 54(Pt 8):749-753. PubMed ID: 16014428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pure or combined inocula of Escherichia coli and Bacteroides fragilis on the liver and related metabolism.
    Rink RD; Kaelin CR; Raque G; Trachtenberg LS; Fry DE
    Lab Invest; 1982 Mar; 46(3):282-7. PubMed ID: 7038296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
    Reznikov M; McDonald PJ
    Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy in polymicrobial infections in a mouse model of type 2 diabetes.
    Mastropaolo MD; Evans NP; Byrnes MK; Stevens AM; Robertson JL; Melville SB
    Infect Immun; 2005 Sep; 73(9):6055-63. PubMed ID: 16113326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin.
    Soriano F; Ponte C; Santamaría M; Castilla C
    J Antimicrob Chemother; 1989 Mar; 23(3):383-8. PubMed ID: 2659565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic synergy between Escherichia coli and Bacteroides fragilis or B. vulgatus in experimental infections: a non-specific phenomenon.
    Verweij-van Vught AM; Namavar F; Vel WA; Sparrius M; MacLaren DM
    J Med Microbiol; 1986 Feb; 21(1):43-7. PubMed ID: 3512833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.